Real Uses for Gene Editing Appearing: Report

News provided by

Nov 22, 2016, 10:19 ET

ROCKVILLE, Md., Nov. 22, 2016 /PRNewswire/ -- A better soybean. A higher-functioning yeast. An AIDS treatment. Engineered lab mice. Kalorama Information says that gene editing technologies have a multitude of commercial applications in numerous fields. The healthcare market researcher said that gene editing is involved the development of human therapeutics, new varieties of plants, new breeds of animals, improved animal models for research, and novel sources of chemicals and energy. Kalorama Information details gene editing applications and companies performing gene editing in its report, Gene Editing Markets.

Gene Editing Markets (CRISPR-based, Zinc Finger Nuclease [ZFN], TALEN, Other) can be found at Kalorama Information: http://www.kaloramainformation.com/Gene-Editing-CRISPR-10347331

"Gene editing is a future growth technology but it is not a futuristic technology," said Bruce Carlson, Publisher of Kalorama Information. "The development of user-friendly tools for gene editing has created a wide range of applications, and there will be more in the future."

Current genome editing technologies encompass several classes of programmable nucleases, including mononucleases, zinc finger nucleases (ZFN), transcription activator-like effector nucleases (TALEN), and CRISPR (clustered regularly interspaced short palindromic repeats)-Cas9nuclease systems. A few examples of such applications are presented in the table below. Kalorama has more information in its report.

Company	Project	Application
Sangamo Biosciences	SB-728-T	HIV/AIDS therapy
Servier/ Pfizer/ Cellectis	UCART19	Acute lymphoblastic leukemia therapy
Sangamo Biosciences	SB-FIX	Hemophilia B
Sichuan University (China)/ Chengdu MedGenCell, Co., Ltd.	PD-1 Knockout T Cells	Metastatic non-small cell lung cancer therapy
Calyxt	Low polyunsaturated fat content soybean	TALEN-engineered soybean
Cibus	SU Canola	RTDS-engineered sulfonylurea-resistant canola
BGI (Beijing Genomics Institute)	Micropigs	TALEN-engineered Bama pigs
Transposagen	Rodent models	TALEN- and CRISPR- engineered rodent models
Nucelis	Squalane	Squalane produced by RTDS-engineered Yarrowia lipolytica yeast

Kalorama Information's report, Gene Editing Markets examines in detail these technologies, as well as the global industry, its structure and major trends affecting it, and provides revenue forecasts by technology, product type, application area, and geographic regions. Profiles of various competitors in this industry are also included in this report. The report can be found on Kalorama's website.

About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.

We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog on our company website.

Contact:
Bruce Carlson
(212) 807-2622
[email protected]
www.KaloramaInformation.com

Logo - http://photos.prnewswire.com/prnh/20150831/262422LOGO

SOURCE Kalorama Information